» Articles » PMID: 25071781

The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. Tuberculosis

Overview
Journal Front Immunol
Date 2014 Jul 30
PMID 25071781
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The Ag85 complex is a 30-32 kDa family of three proteins (Ag85A, Ag85B, and Ag85C), which all three possess enzymatic mycolyl-transferase activity involved in the coupling of mycolic acids to the arabinogalactan of the cell wall and in the biogenesis of cord factor. By virtue of their strong potential to induce Th1-type immune responses, important for the control of intracellular infections, members of the Ag85 family rank among the most promising TB vaccine candidate antigens. Ag85A and Ag85B, initially purified from Mycobacterium bovis bacillus Calmette-Guérin (BCG)/Mycobacterium tuberculosis culture filtrate respectively, induce strong T-cell proliferation and IFN-γ production in most healthy individuals latently infected with M. tuberculosis and in BCG-vaccinated mice and humans but not in tuberculosis patients. Members of the Ag85 complex are highly conserved in other mycobacterial species. Mice and humans infected with Mycobacterium ulcerans or cattle infected with M. bovis or Mycobacterium avium subsp. paratuberculosis also show strong T-cell responses to this protein family. Using synthetic overlapping peptides, bio-informatic prediction programs and tetramer-binding studies, a number of immunodominant CD4(+) and CD8(+) T-cell epitopes have been identified in experimental animal models as well as in humans, using proliferation and Th1 cytokine secretion as main read-outs. The results from these studies are summarized in this review.

Citing Articles

Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against .

Yun J, Shin E, Lee Y, Lee J, Lee H, Kim J Front Microbiol. 2025; 16:1492268.

PMID: 39927262 PMC: 11802578. DOI: 10.3389/fmicb.2025.1492268.


Bioinformatics Analysis and Immunogenicity Assessment of the Novel Multi-Stage DNA Vaccine W541 Against Mycobacterium Tuberculosis.

Yang Y, Xue Y, Wang X, Wang L, Wang J, Zhang J Immun Inflamm Dis. 2024; 12(11):e70074.

PMID: 39588938 PMC: 11590035. DOI: 10.1002/iid3.70074.


Relative Importance of Defined Mycobacterium tuberculosis Antigens in the T-Cell Recognition Repertoire of Latently Infected Individuals Not Progressing to Active Disease.

Oftung F, Mustafa A Med Princ Pract. 2024; 34(1):66-74.

PMID: 39476812 PMC: 11805546. DOI: 10.1159/000542324.


Fluorogenic Probes of the Mycobacterial Membrane as Reporters of Antibiotic Action.

Wuo M, Dulberger C, Warner T, Brown R, Sturm A, Ultee E J Am Chem Soc. 2024; 146(26):17669-17678.

PMID: 38905328 PMC: 11646346. DOI: 10.1021/jacs.4c00617.


Adolescent BCG revaccination induces a phenotypic shift in CD4 T cell responses to Mycobacterium tuberculosis.

Dintwe O, Ballweber Fleming L, Voillet V, McNevin J, Seese A, Naidoo A Nat Commun. 2024; 15(1):5191.

PMID: 38890283 PMC: 11189459. DOI: 10.1038/s41467-024-49050-1.


References
1.
Finan C, Ota M, Marchant A, Newport M . Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants. PLoS One. 2008; 3(10):e3485. PMC: 2567029. DOI: 10.1371/journal.pone.0003485. View

2.
Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg T, Vanonckelen A . Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun. 1998; 66(4):1527-33. PMC: 108084. DOI: 10.1128/IAI.66.4.1527-1533.1998. View

3.
Weichold F, Mueller S, Kortsik C, Hitzler W, Wulf M, Hone D . Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun. 2007; 8(4):334-43. DOI: 10.1038/sj.gene.6364392. View

4.
Roche P, Peake P, Billman-Jacobe H, Doran T, Britton W . T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun. 1994; 62(12):5319-26. PMC: 303271. DOI: 10.1128/iai.62.12.5319-5326.1994. View

5.
Brennan M, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo A . Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine. 2012; 30(18):2811-23. PMC: 3335191. DOI: 10.1016/j.vaccine.2012.02.036. View